{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:09:28Z","timestamp":1791846568335,"version":"4.3.4"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T00:00:00Z","timestamp":1639699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"direcci\u00f3n de investigaci\u00f3n, universidad peruana de ciencias aplicadas, lima, peru","award":["B-016-2020"],"award-info":[{"award-number":["B-016-2020"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      In the last years the rapid expansion of multidrug-resistant\n                      <jats:italic>A<\/jats:italic>\n                      .\n                      <jats:italic>baumannii<\/jats:italic>\n                      strains have become a major health problem. Efflux pumps are a group of transport proteins that contribute to the development of antibiotic resistance. The aim of this study was to evaluate the effect of the efflux pump inhibitor carbonyl cyanide 3-chlorophenylhydrazone (CCCP) on the antimicrobial action of imipenem and cefepime on clinical strains of\n                      <jats:italic>A<\/jats:italic>\n                      .\n                      <jats:italic>baumannii<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      A total of 49 non-duplicate clinical samples were collected during January through December of 2018 from patients hospitalized in the\n                      <jats:italic>Hospital Regional Docente de Cajamarca<\/jats:italic>\n                      . Of the 49 samples obtained, the confirmatory identification of\n                      <jats:italic>A<\/jats:italic>\n                      .\n                      <jats:italic>baumannii<\/jats:italic>\n                      was performed on 47 samples by molecular methods. The amplification of the bla\n                      <jats:italic>OXA-51-like gene<\/jats:italic>\n                      was carried out by polymerase chain reaction (PCR). The determination of the minimum inhibitory concentration (MIC) was calculated using the microdilution method in culture broth. The susceptibility to both antibiotics (cefepime and imipenem) was evaluated in the presence and absence of the inhibitor carbonyl cyanide 3-chlorophenylhydrazone (CCCP).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 47 strains of\n                      <jats:italic>A<\/jats:italic>\n                      .\n                      <jats:italic>baumannii<\/jats:italic>\n                      were isolated: 97.87% (46\/47) were resistant to Imipenem, 2.13% (1\/47) of them were classified as intermediate and none of these strains were susceptible. On the other hand, 51.06% (24\/47) of isolates were resistant to cefepime; 19.15% (9\/47) intermediate and 29.79% (14\/47) susceptible. We considered a significant difference in antibiotic susceptibility if the MIC changed at least 4 dilutions, after the addition of the inhibitor. In the case of CCCP in addition to imipenem, 2.1% (1\/47) had a significant change of 4 or more reductions in MIC, 59.6% (28\/47) achieved a change equal or less than 3 dilutions and 17.0% (8\/47) did not have any change. In the case of CCCP with cefepime the percentage of strains with the significant change of MIC was 8.5% (4\/47). On the other hand, 53.2% (24\/47) presented a reduction equal or less than 3 dilutions and 12.8% (6\/47) did not show changes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      In conclusion, our results demonstrate that the use of CCCP may improve the antibiotic effect of imipenem and cefepime on clinical strains of\n                      <jats:italic>A<\/jats:italic>\n                      .\n                      <jats:italic>baumannii<\/jats:italic>\n                      . The relevance of this study is that it provides evidence that this efflux pump inhibitor may be an alternative treatment against multidrug-resistant\n                      <jats:italic>A<\/jats:italic>\n                      .\n                      <jats:italic>baumannii<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0259915","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T13:27:09Z","timestamp":1639747629000},"page":"e0259915","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["The effect of the efflux pump inhibitor Carbonyl Cyanide m-Chlorophenylhydrazone (CCCP) on the susceptibility to imipenem and cefepime in clinical strains of Acinetobacter baumannii"],"prefix":"10.1371","volume":"16","author":[{"given":"Alejandra","family":"Sanchez-Carbonel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2935-0608","authenticated-orcid":true,"given":"Bel\u00e9n","family":"Mondrag\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s","family":"L\u00f3pez-Chegne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Pe\u00f1a-Tuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys","family":"Huayan-D\u00e1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9986-7442","authenticated-orcid":true,"given":"Dora","family":"Blitchtein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7886-8895","authenticated-orcid":true,"given":"Hugo","family":"Carrillo-Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilmer","family":"Silva-Caso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel","family":"Aguilar-Luis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6011-5040","authenticated-orcid":true,"given":"Juana","family":"del Valle-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,12,17]]},"reference":[{"issue":"3","key":"pone.0259915.ref001","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/2049-632X.12125","article-title":"Acinetobacter baumannii: evolution of a global pathogen","volume":"71","author":"LC Antunes","year":"2014","journal-title":"Pathog Dis"},{"key":"pone.0259915.ref002","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jgar.2020.02.027","article-title":"Hyper-expression of the efflux pump gene adeB was found in Acinetobacter baumannii with decreased triclosan susceptibility","volume":"22","author":"K Yu","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"issue":"12","key":"pone.0259915.ref003","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1128\/AAC.01520-13","article-title":"Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes","volume":"57","author":"T Chopra","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0259915.ref004","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2217\/fmb-2016-0158","article-title":"Clinical and molecular epidemiology of Acinetobacter baumannii bloodstream infections in an endemic setting","volume":"12","author":"D Marchaim","year":"2017","journal-title":"Future Microbiol"},{"issue":"3","key":"pone.0259915.ref005","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4161\/viru.19700","article-title":"Acinetobacter baumannii: an emerging opportunistic pathogen","volume":"3","author":"A Howard","year":"2012","journal-title":"Virulence"},{"issue":"3","key":"pone.0259915.ref006","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"E Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"pone.0259915.ref007","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/499819","article-title":"Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America","volume":"42","author":"Antimicrobial Availability Task Force of the Infectious Diseases Society of America","year":"2006","journal-title":"Clin Infect Dis"},{"key":"pone.0259915.ref008","unstructured":"Organizaci\u00f3n Panamericana de la Salud. Organizaci\u00f3n M de la S. Informe Anual de la red de monitore\/vigilancia de la resistencia a los antibioticos. Vol. 38, Informe Anual de la red de monitore\/vigilancia de la resistencia a los antibioticos. Lima, Peru; 2009."},{"issue":"3","key":"pone.0259915.ref009","first-page":"327","article-title":"Carbapenemases in Acinetobacter baumannii. Review of their dissemination in Latin America","volume":"50","author":"CH Rodr\u00edguez","year":"2018","journal-title":"Rev Argent Microbiol"},{"issue":"11","key":"pone.0259915.ref010","first-page":"2602","article-title":"Acinetobacter baumannii: A Brief Account of Mechanisms of Multidrug Resistance and Current and Future Therapeutic Management","volume":"7","author":"H Singh","year":"2013","journal-title":"J Clin Diagn Res"},{"issue":"11","key":"pone.0259915.ref011","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1128\/AAC.03535-14","article-title":"Identification of Acinetobacter baumannii serum-associated antibiotic efflux pump inhibitors","volume":"58","author":"C Blanchard","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"MAR","key":"pone.0259915.ref012","article-title":"Biology of Acinetobacter baumannii: Pathogenesis, antibiotic resistance mechanisms, and prospective treatment options","volume":"7","author":"CR Lee","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"pone.0259915.ref013","doi-asserted-by":"crossref","first-page":"8691","DOI":"10.5812\/jjm.8691","article-title":"Effect of Efflux Pump Inhibitor Carbonyl Cyanide 3-Chlorophenylhydra-zone on the Minimum Inhibitory Concentration of Ciprofloxacin in Acineto-bacter baumannii Clinical Isolates","volume":"7","author":"A Ardebili","year":"2014","journal-title":"Jundishapur J Microbiol"},{"key":"pone.0259915.ref014","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2019.100547","article-title":"Role of efflux pumps in reduced susceptibility to tigecycline in Acinetobacter baumannii","volume":"30","author":"SH Ardehali","year":"2019","journal-title":"New Microbes New Infect"},{"key":"pone.0259915.ref015","unstructured":"Alavi-Moghadam M. Incidence of imipenem-resistant Acinetobacter baumannii in a general intensive care unit (ICU). Vol. 5, Caspian J Intern Med. 2014."},{"issue":"5","key":"pone.0259915.ref016","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0769-2609(87)90042-1","article-title":"Identification and biotyping of clinical isolates of Acinetobacter","volume":"138","author":"PJM Bouvet","year":"1987","journal-title":"Ann Inst Pasteur Microbiol"},{"issue":"April","key":"pone.0259915.ref017","first-page":"64","article-title":"Acinetobacter spp.: microbiological, clinical and epidemiological aspects","volume":"25","author":"EZ Salazar de Vegasa","year":"2005","journal-title":"Rev la Soc Venez Microbiol"},{"issue":"3","key":"pone.0259915.ref018","doi-asserted-by":"crossref","first-page":"99","DOI":"10.15324\/kjcls.2014.46.3.99","article-title":"Improved DNA Extraction Method for Molecular Diagnosis from Smaller numbers of Cells","volume":"46","author":"SY Oh","year":"2014","journal-title":"Korean J Clin Lab Sci"},{"issue":"11","key":"pone.0259915.ref019","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1128\/AAC.01512-06","article-title":"An OXA-66\/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii","volume":"51","author":"WS Hu","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"pone.0259915.ref020","doi-asserted-by":"crossref","first-page":"e0158958","DOI":"10.1371\/journal.pone.0158958","article-title":"Two Multiplex Real-Time PCR Assays to Detect and Differentiate Acinetobacter baumannii and Non- baumannii Acinetobacter spp. Carrying blaNDM, blaOXA-23-Like, blaOXA-40-Like, blaOXA-51-Like, and blaOXA-58-Like Genes","volume":"11","author":"Q Yang","year":"2016","journal-title":"PLoS One"},{"key":"pone.0259915.ref021","unstructured":"Clinical and Laboratory Standards Institute. M07-A10 Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Tenth Edition [Internet]. 2015 [cited 2020 Mar 31]. www.clsi.org."},{"key":"pone.0259915.ref022","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, 30th Edition [Internet]. 2020 [cited 2020 Mar 31]. http:\/\/em100.edaptivedocs.net\/GetDoc.aspx?doc=CLSIM100ED30:2020&scope=user"},{"issue":"10","key":"pone.0259915.ref023","first-page":"e19048","article-title":"Efflux Pump Inhibitor Phenylalanine-Arginine \u0392-Naphthylamide Effect on the Minimum Inhibitory Concentration of Imipenem in Acinetobacter baumannii Strains Isolated From Hospitalized Patients in Shahid Motahari Burn Hospital, Tehran","volume":"8","author":"M Gholami","year":"2015","journal-title":"Iran. Jundishapur J Microbiol"},{"issue":"8","key":"pone.0259915.ref024","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1128\/JCM.00367-08","article-title":"Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California","volume":"46","author":"SC Valentine","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"5","key":"pone.0259915.ref025","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1093\/jac\/dkl081","article-title":"Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamide","volume":"57","author":"S Pannek","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"pone.0259915.ref026","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/jac\/dkl509","article-title":"Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii","volume":"59","author":"J Vila","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"pone.0259915.ref027","first-page":"31","article-title":"Analysis of global prevalence of antibiotic resistance in Acinetobacter baumannii infections disclosed a faster increase in OECD countries","volume":"7","author":"R Xie","year":"2018","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"pone.0259915.ref028","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41426-018-0127-9","article-title":"Emergence and spread of carbapenem-resistant Acinetobacter baumannii international clones II and III in Lima, Peru","volume":"7","author":"S Levy-Blitchtein","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"pone.0259915.ref029","unstructured":"Carlos R, Far\u00edas B, P\u00e9rez Ponce LJ, Castro Vega G, Pujol P\u00e9rez M, Barletta Del Castillo JE, et al. Acinetobacter baumannii multirresistente: un reto para la terap\u00e9utica actual Multidrug-resistant Acinetobacter baumannii: a challange for current therapeutic. 2018."},{"key":"pone.0259915.ref030","unstructured":"Garcia- Rivera M, Ram\u00edrez R, Pereira M, Montes R, Gamarra. R., Garc\u00eda-de-la-Guarda R. Infecci\u00f3n nosocomial por Acinetobacter Baumannii resistentes a antimicrobianos en pacientes internados en un hospital de nivel IV, Lima\u2013Per\u00fa. Lima; 2015."},{"issue":"4","key":"pone.0259915.ref031","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics8040229","article-title":"Effectiveness of efflux pump inhibitors as biofilm disruptors and resistance breakers in gram- negative (ESKAPEE) bacteria","volume":"8","author":"A Reza","year":"2019","journal-title":"Antibiotics"},{"issue":"3","key":"pone.0259915.ref032","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1128\/AAC.01388-10","article-title":"Efflux-Mediated Antibiotic Resistance in Acinetobacter spp","volume":"55","author":"S Coyne","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pone.0259915.ref033","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/157489109787236256","article-title":"Inhibitors of Multidrug Resistant Efflux Systems in Bacteria","volume":"4","author":"B Zechini","year":"2009","journal-title":"Recent Pat Antiinfect Drug Discov"},{"issue":"3","key":"pone.0259915.ref034","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.phrp.2011.11.040","article-title":"Alterations of gyrA, gyrB, and parC and Activity of Efflux Pump in Fluoroquinolone-resistant Acinetobacter baumannii","volume":"2","author":"S Park","year":"2011","journal-title":"Osong Public Heal Res Perspect"},{"issue":"2","key":"pone.0259915.ref035","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/jac\/dkp427","article-title":"Novel role of Acinetobacter baumannii RND efflux transporters in mediating decreased susceptibility to biocides","volume":"65","author":"G Rajamohan","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"pone.0259915.ref036","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijantimicag.2008.06.027","article-title":"Distribution of the multidrug efflux pump genes, adeABC, adeDE and adeIJK, and class 1 integron genes in multiple-antimicrobial-resistant clinical isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex","volume":"33","author":"L Lin","year":"2009","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"pone.0259915.ref037","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/ijmr.IJMR_2079_17","article-title":"Efflux pump inhibitors for bacterial pathogens: From bench to bedside","volume":"149","author":"A Sharma","year":"2019","journal-title":"Indian J Med Res"},{"issue":"6","key":"pone.0259915.ref038","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3390\/microorganisms8060935","article-title":"Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii","volume":"8","author":"CO Vrancianu","year":"2020","journal-title":"Microorganisms"},{"issue":"9","key":"pone.0259915.ref039","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/antibiotics9090623","article-title":"Overcoming Intrinsic and Acquired Resistance Mechanisms Associated with the Cell Wall of Gram-Negative Bacteria","volume":"9","author":"RE Impey","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"pone.0259915.ref040","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1038\/s41598-019-39659-4","article-title":"A permeability-increasing drug synergizes with bacterial efflux pump inhibitors and restores susceptibility to antibiotics in multi-drug resistant Pseudomonas aeruginosa strains","volume":"9","author":"R Ferrer-Espada","year":"2019","journal-title":"Sci Rep"},{"issue":"4","key":"pone.0259915.ref041","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.tim.2018.10.007","article-title":"The Eagle Effect and Antibiotic-Induced Persistence: Two Sides of the Same Coin?","volume":"27","author":"A Prasetyoputri","year":"2019","journal-title":"Trends Microbiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0259915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T13:27:52Z","timestamp":1639747672000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0259915"}},"subtitle":[],"editor":[{"given":"Iddya","family":"Karunasagar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,12,17]]},"references-count":41,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0259915","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,17]]}}}